N. M. Grindler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
N. M. Grindler has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
A.J. Polotsky
OBGYN, Division of REI, University of Colorado, Aurora, CO
2 shared publicationsI. Yang
Department of Medicine and Integrated Center for Genes, Environment, and Health, University of Colorado, Aurora, CO
2 shared publicationsK. Kannan
New York State Dept of Health, Albany, NY
2 shared publicationsK. Rajendiran
New York State Dept of Health, Albany, NY
2 shared publicationsS. Teal
Department of OBGYN, Division of Family Planning, Anschutz Medical Campus, University of Colorado Hospital, 12605 E. 16th Ave., Aurora, CO, 80045, USA
2 shared publications- Thomas Jansson
OBGYN, Division of Reproductive Sciences, University of Colorado, Aurora, CO
2 shared publications
Latest Publications
- Open Access
- 16 May 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (5) , e0195375
OBGYN screening for environmental exposures: A call for action
Prenatal exposures have known adverse effects on maternal and neonatal outcomes. Professional societies recommend routine screening for environmental, occupational, and dietary exposures to reduce exposures and their associated sequelae. Our objective was to determine the frequency of environmental exposure screening by obstetricians and gynecologists (OBGYNs) at initial patient visits. Practicing OBGYNs were approached at the University of Colorado and by social media. The survey instrument queried demographics, environmental literacy, and screening practices. Statistical analysis was performed using Chi-square and two-sample t-test. We received 312 online survey responses (response rate of 12%). Responding OBGYNs were predominantly female (96%), board-certified (78%), generalists (65%) with a mean age of 37.1 years. Fewer than half of physicians screened for the following factors: occupational exposures, environmental chemicals, air pollution, pesticide use, personal care products, household cleaners, water source, use of plastics for food storage, and lead and mercury exposure. Eighty five percent of respondents reported that they did not feel comfortable obtaining an environmental history and 58% respondents reported that they performed no regular screening of environmental exposures. A higher frequency of screening was associated with > 4 years of practice (p = 0.001), and having read the environmental committee opinion (p = <0.001). The majority of OBGYNs did not incorporate screening for known environmental exposures into routine practice. Reading the environmental committee opinions was strongly and significantly associated with a higher rate of screening. Improving physician comfort in counseling patients may enhance screening for exposures that affect reproductive health.
- 16 May 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (5) , e0195375
Open AccessOBGYN screening for environmental exposures: A call for action
Prenatal exposures have known adverse effects on maternal and neonatal outcomes. Professional societies recommend routine screening for environmental, occupational, and dietary exposures to reduce exposures and their associated sequelae. Our objective was to determine the frequency of environmental exposure screening by obstetricians and gynecologists (OBGYNs) at initial patient visits. Practicing OBGYNs were approached at the University of Colorado and by social media. The survey instrument queried demographics, environmental literacy, and screening practices. Statistical analysis was performed using Chi-square and two-sample t-test. We received 312 online survey responses (response rate of 12%). Responding OBGYNs were predominantly female (96%), board-certified (78%), generalists (65%) with a mean age of 37.1 years. Fewer than half of physicians screened for the following factors: occupational exposures, environmental chemicals, air pollution, pesticide use, personal care products, household cleaners, water source, use of plastics for food storage, and lead and mercury exposure. Eighty five percent of respondents reported that they did not feel comfortable obtaining an environmental history and 58% respondents reported that they performed no regular screening of environmental exposures. A higher frequency of screening was associated with > 4 years of practice (p = 0.001), and having read the environmental committee opinion (p = <0.001). The majority of OBGYNs did not incorporate screening for known environmental exposures into routine practice. Reading the environmental committee opinions was strongly and significantly associated with a higher rate of screening. Improving physician comfort in counseling patients may enhance screening for exposures that affect reproductive health.
- Open Access
- 17 April 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-9
Exposure to Phthalate, an Endocrine Disrupting Chemical, Alters the First Trimester Placental Methylome and Transcriptome in Women
Phthalates are known endocrine disruptors and associated with decreased fecundity, pregnancy loss, and adverse obstetrical outcomes, however the underlying mechanisms remain to be established. Environmental factors can influence gene expression and cell function by modifying epigenetic marks, impacting the developing embryo as well as future generations of offspring. The impact of phthalates on placental gene methylation and expression is largely unknown. We studied the effect of maternal phthalate exposure on the human placental DNA methylome and transcriptome. We determined epigenome-wide DNA methylation marks (Illumina Infinium Human Methylation 850k BeadChip) and gene expression (Agilent whole human genome array) associated with phthalate exposure in first trimester placenta. Integrative genomic analysis of candidate genes was performed to define gene methylation-expression relationships. We identified 39 genes with significantly altered methylation and gene expression in the high phthalate exposure group. Most of these relationships were inversely correlated. This analysis identified epidermal growth factor receptor (EGFR) as a critical candidate gene mediating the effects of phthalates on early placental function. Although additional studies are needed to determine the functional consequences of these changes, our findings are consistent with the model that phthalates impact placental function by modulating the expression of critical placental genes through epigenetic regulation.
- 17 April 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-9
Open AccessExposure to Phthalate, an Endocrine Disrupting Chemical, Alters the First Trimester Placental Methylome and Transcriptome in Women
Phthalates are known endocrine disruptors and associated with decreased fecundity, pregnancy loss, and adverse obstetrical outcomes, however the underlying mechanisms remain to be established. Environmental factors can influence gene expression and cell function by modifying epigenetic marks, impacting the developing embryo as well as future generations of offspring. The impact of phthalates on placental gene methylation and expression is largely unknown. We studied the effect of maternal phthalate exposure on the human placental DNA methylome and transcriptome. We determined epigenome-wide DNA methylation marks (Illumina Infinium Human Methylation 850k BeadChip) and gene expression (Agilent whole human genome array) associated with phthalate exposure in first trimester placenta. Integrative genomic analysis of candidate genes was performed to define gene methylation-expression relationships. We identified 39 genes with significantly altered methylation and gene expression in the high phthalate exposure group. Most of these relationships were inversely correlated. This analysis identified epidermal growth factor receptor (EGFR) as a critical candidate gene mediating the effects of phthalates on early placental function. Although additional studies are needed to determine the functional consequences of these changes, our findings are consistent with the model that phthalates impact placental function by modulating the expression of critical placental genes through epigenetic regulation.
- 1 September 2016
- Published by Elsevier in Fertility and Sterility
- Vol. 106 (3) , e27
The effect of the endocrine disrupting chemical DEHP on the ovarian and adipose transcriptome
- 1 September 2016
- Published by Elsevier in Fertility and Sterility
- Vol. 106 (3) , e27
The effect of the endocrine disrupting chemical DEHP on the ovarian and adipose transcriptome
- 1 September 2016
- Published by Elsevier in Fertility and Sterility
- Vol. 106 (3) , e28
Exposure to phthalate, an endocrine disrupting chemical, alters first trimester placental gene expression in women
- 1 September 2016
- Published by Elsevier in Fertility and Sterility
- Vol. 106 (3) , e28
Exposure to phthalate, an endocrine disrupting chemical, alters first trimester placental gene expression in women
- 1 September 2012
- Published by Elsevier in Fertility and Sterility
- Vol. 98 (3) , S227
State-mandated insurance coverage impacts the approach to hydrosalpinges prior to IVF
- 1 September 2012
- Published by Elsevier in Fertility and Sterility
- Vol. 98 (3) , S227
State-mandated insurance coverage impacts the approach to hydrosalpinges prior to IVF